INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

KODKodiak Sciences Inc.

CIK 0001468748

EDGAR filingsOpen in network
Disclosed transactions23
Buys / sells0 / 8
Max Insider Score26
Connections4with evidence

KOD · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
YT
Yang TaiyinDirector
KODKodiak Sciences Inc.
Option exercise
M—
20.0K sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Yang TaiyinDirector · Oct 26, 2026
  • ← Insider ofevidence
    Borgeson John A.Chief Financial Officer · Apr 16, 2026
  • ← Insider ofevidence
    Perlroth VictorDirector, Chairman and CEO · Mar 19, 2026
9
YT
Yang TaiyinDirector
KODKodiak Sciences Inc.
Option exercise
M
$47K
20.0K sh
Oct 23, 2026
Oct 26, 2026
traded Oct 23, 2026
+3d
SEC FORM 4

Evidence

11
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$746K
8,514 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

8
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$150K
1,677 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

11
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$684K
7,623 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

11
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$464K
5,101 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

11
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$274K
2,985 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

8
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$185K
2,000 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

8
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$187K
2,000 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

3
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Option exercise · 10b5-1 plan
M—
30.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

5
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$9,491
100 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

6
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Option exercise · 10b5-1 plan
M$75K
30.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

9
PV
Perlroth VictorDirector, Chairman and CEO, 10% Owner
KODKodiak Sciences Inc.
Option exercise
M—
314.7K sh
Sep 25, 2026Sep 29, 2026
traded Sep 25, 2026
+4dSEC FORM 4

Evidence

26
PV
Perlroth VictorDirector, Chairman and CEO, 10% Owner
KODKodiak Sciences Inc.
Option exercise
M$3.23M
600.0K sh
Sep 25, 2026Sep 29, 2026
traded Sep 25, 2026
+4dSEC FORM 4

Evidence

19
PV
Perlroth VictorDirector, Chairman and CEO, 10% Owner
KODKodiak Sciences Inc.
Option exercise
M$911K
365.8K sh
Sep 25, 2026Sep 29, 2026
traded Sep 25, 2026
+4dSEC FORM 4

Evidence

22
PV
Perlroth VictorDirector, Chairman and CEO, 10% Owner
KODKodiak Sciences Inc.
Option exercise
M$1.24M
314.7K sh
Sep 25, 2026Sep 29, 2026
traded Sep 25, 2026
+4dSEC FORM 4

Evidence

9
PV
Perlroth VictorDirector, Chairman and CEO, 10% Owner
KODKodiak Sciences Inc.
Option exercise
M—
600.0K sh
Sep 25, 2026Sep 29, 2026
traded Sep 25, 2026
+4dSEC FORM 4

Evidence

9
PV
Perlroth VictorDirector, Chairman and CEO, 10% Owner
KODKodiak Sciences Inc.
Option exercise
M—
365.8K sh
Sep 25, 2026Sep 29, 2026
traded Sep 25, 2026
+4dSEC FORM 4

Evidence

13
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Option exercise
M$30K
28.6K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC FORM 4

Evidence

21
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Option exercise
M—
28.6K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC FORM 4

Evidence

19
PV
Perlroth VictorDirector, Chairman and CEO
KODKodiak Sciences Inc.
Option exercise
M$312K
300.0K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

9
PV
Perlroth VictorDirector, Chairman and CEO
KODKodiak Sciences Inc.
Option exercise
M—
300.0K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

9
PV
Perlroth VictorDirector, Chairman and CEO
KODKodiak Sciences Inc.
Grant or award
A—
175.0K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence